These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


73 related items for PubMed ID: 2507419

  • 1. The prognostic significance of bone lesions in multiple myeloma.
    Bettini R, Anzani P, Quadrelli CM, Mammano S.
    Haematologica; 1989; 74(4):414-6. PubMed ID: 2507419
    [No Abstract] [Full Text] [Related]

  • 2. [Prognostic significance of skeletal lesions in multiple myeloma].
    Bettini R, Anzani P, Quadrelli CM, Mammano S, Rapazzini P, Marrapodi E, Sessa V.
    Recenti Prog Med; 1989 Jun; 80(6):300-3. PubMed ID: 2672192
    [Abstract] [Full Text] [Related]

  • 3. [IgD multiple myeloma (with 2 cases showing diffuse sclerotic bone lesions) (author's transl)].
    Zhang A, Huang WX, Jiang YL, Wu AR, He XM, Nie LC.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1979 Dec; 1(2):101-6. PubMed ID: 262821
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The prognostic significance of bone lesions in multiple myeloma.
    Bettini R, Anzani P, Quadrelli CM, Mammano S.
    Haematologica; 1989 Dec; 74(3):335. PubMed ID: 2511109
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Link between osteoclastogenesis, angiogenesis and myeloma expansion].
    Abe M.
    Clin Calcium; 2008 Apr; 18(4):473-9. PubMed ID: 18379029
    [Abstract] [Full Text] [Related]

  • 17. [Prognostic and therapeutic significance of bone marrow biopsy in multiple myeloma. Analysis of 31 stage II A and III A patients].
    Paule B, Quillard J, Medicis P, Bourgeois P, Grossin M, Bisson M, Kahn MF.
    Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):27-32. PubMed ID: 3353673
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors in multiple myeloma: selection using Cox's proportional hazard model.
    Pasqualetti P, Collacciani A, Maccarone C, Casale R.
    Biomed Pharmacother; 1996 Jan; 50(1):29-35. PubMed ID: 8672729
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF, Fu WJ, Yuan ZG, Wang DX, Chen YB, Hou J.
    Chin Med J (Engl); 2007 Oct 05; 120(19):1655-8. PubMed ID: 17935664
    [Abstract] [Full Text] [Related]

  • 20. [Simultaneous occurrence of hyperparathyroidism and multiple myeloma].
    Peters KM, Rosenberger J, Gaczkowski A, Lorenz R.
    Internist (Berl); 1989 Feb 05; 30(2):117-9. PubMed ID: 2647651
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.